Pharmaceutical Research Center

药物研究中心

基本信息

项目摘要

DESCRIPTION (provided by applicant): Pharmaceutical Research Center: This application seeks to continue the evolution of the Pharmaceutical Research Center at Florida A&M University (FAMU). The previously funded targeted research activities have demonstrated productivity and resulted in significant discoveries that have led to the award of several patents and additional pending discoveries. Based on the evaluation of the current research infrastructure and the strategic needs of the program, it is proposed to transition the targeted activities into the development of Core research facilities. The main objective of the current application is to build the infrastructure of the research program towards more understanding of the mechanistic details of the molecular system. This RCMI center will focus efforts on approaches, i.e., gene expression analysis, proteomics, PCR analysis, gene delivery systems and DNA picroarray techniques. The establishment of Core facilities in the areas of molecular neurobiology, cellular imaging, neurochemistry/receptors, flow cytometry and nanomedicine will increase our abilities to understand the mechanistic details of the molecular system and to provide greater insights into how the different molecular are modulated under disease and adverse conditions. The Pharmaceutical Research Center will consist of a research administrative component coupled with four (4) core service delivery facilities. The administrative component will continue to provide pre- and post- award assistance, coordinate the activities of the external and internal advisory committee, provide scientific seminars and grants workshops, coordinate a new structured mentoring program, facilitate an extensive external evaluation of program outcomes, assist in faculty development, hire a research faculty member and market and conduct an on-site grants management workshop and the annual RCMI R01 Scientist Seminar Series. Specific aim one (1) is to transition the program from the current research programs in neuroscience, drug delivery, and molecular biology to research cores focusing on Neurodegeneration research, Nanomedicine research, drug discovery and biotechnology: pathways to disease prevention and therapy. Through this network of Core facilities, the Pharmaceutical Research Center will foster inter- and inter-disciplinary research. Aim two (2) is to increase research investigators capabilities and competitiveness to receive four (4) investigators initiated grants. Aim three (3) is to assure the completion of program objectives and outcomes through a comprehensive formative and summative evaluation process. Aim four (4) is to address health disparities through research emphasis on those conditions that adversely impact disadvantaged populations and produce additional minority scientists who will address disparities. This RCMI Program has been transformational at FAMU. Ensuring translational research is at the forefront of the proposed research activities as we seek to accelerate the utilization of our biomedical discoveries. The College's motto is "Funding Cures and Saving Lives."
描述(由申请人提供):制药研究中心:该申请旨在继续佛罗里达农工大学(FAMU)的药物研究中心的发展。先前资助的有针对性的研究活动已经证明了生产力,并导致了重大发现,从而授予了几项专利和其他未决的发现。根据对当前研究基础设施和计划的战略需求的评估,建议将目标活动转变为核心研究设施的发展。当前应用的主要目的是建立研究计划的基础设施,以更多地了解分子系统的机械细节。这个RCMI中心将重点放在方法上,即基因表达分析,蛋白质组学,PCR分析,基因输送系统和DNA Picroarray技术。在分子神经生物学,细胞成像,神经化学/受体,流式细胞术和纳米医学领域的核心设施建立将提高我们的能力,以了解分子系统的机理细节,并提供更大的见解,以提供在疾病和不良条件下如何调节不同分子的能力。药物研究中心将由研究管理组成部分以及四(4)个核心服务提供机构组成。 The administrative component will continue to provide pre- and post- award assistance, coordinate the activities of the external and internal advisory committee, provide scientific seminars and grants workshops, coordinate a new structured mentoring program, facilitate an extensive external evaluation of program outcomes, assist in faculty development, hire a research faculty member and market and conduct an on-site grants management workshop and the annual RCMI R01 Scientist Seminar Series.具体目的一(1)是将该程序从当前的神经科学,药物输送和分子生物学的研究计划转变为关注神经退行性研究,纳米医学研究,药物发现和生物技术的研究核心:预防疾病和治疗的途径。通过这个核心设施网络,制药研究中心将培养跨学科研究。目标两(2)是提高研究人员的能力和竞争力,以获得四(4)个调查人员的赠款。目标三(3)是通过全面的形成性和总结性评估过程来确保计划目标和成果的完成。目标四(4)是通过研究强调那些不利影响弱势群体并产生其他将解决差异的少数族裔科学家来解决健康差异的问题。该RCMI计划在FAMU方面具有变革性。当我们试图加速生物医学发现的利用时,确保转化研究处于拟议研究活动的最前沿。该学院的座右铭是“筹集资金并挽救生命”。

项目成果

期刊论文数量(163)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Role of DNA Mismatch Repair and Recombination in the Processing of DNA Alkylating Damage in Living Yeast Cells.
A modified HPLC method for monensin analysis in liposomes and nanocapsules and its comparison with spectrophotometric and radioactive methods.
Disentangling the influence of socioeconomic status on differences between African American and white women in unmet medical needs.
理清社会经济地位对非裔美国女性和白人女性未满足医疗需求差异的影响。
  • DOI:
    10.2105/ajph.2008.154088
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    12.7
  • 作者:
    Wiltshire,JacquelineC;Person,SharinaD;Kiefe,CatarinaI;Allison,JeroanJ
  • 通讯作者:
    Allison,JeroanJ
Maternal factors and disparities associated with oral clefts.
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Kimberly Lebby;Fei Tan;C. P. Brown
  • 通讯作者:
    Kimberly Lebby;Fei Tan;C. P. Brown
Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.
  • DOI:
    10.1016/j.neuro.2012.06.009
  • 发表时间:
    2012-10
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Mazzio E;Soliman KF
  • 通讯作者:
    Soliman KF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KARAM F.A. SOLIMAN其他文献

KARAM F.A. SOLIMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KARAM F.A. SOLIMAN', 18)}}的其他基金

Biotechnology Core
生物技术核心
  • 批准号:
    9360190
  • 财政年份:
    2015
  • 资助金额:
    $ 234.09万
  • 项目类别:
Recruitment and Hiring
招聘与聘用
  • 批准号:
    9360189
  • 财政年份:
    2015
  • 资助金额:
    $ 234.09万
  • 项目类别:
Hypoxia and anaerobic metabolism regulation of cancer cell survival: a novel mol
缺氧和无氧代谢调节癌细胞存活:一种新的分子机制
  • 批准号:
    8552024
  • 财政年份:
    2013
  • 资助金额:
    $ 234.09万
  • 项目类别:
Center of Excellence for Cancer Research, Training and Community Service
癌症研究、培训和社区服务卓越中心
  • 批准号:
    8804857
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8355101
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:
Hypoxia and anaerobic metabolism regulation of cancer cell survival: a novel mol
缺氧和无氧代谢调节癌细胞存活:一种新的分子机制
  • 批准号:
    8355085
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:
Center of Excellence for Cancer Research, Training and Community Service
癌症研究、培训和社区服务卓越中心
  • 批准号:
    8491915
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:
Center of Excellence for Cancer Research, Training and Community Service
癌症研究、培训和社区服务卓越中心
  • 批准号:
    8254919
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:
Center of Excellence for Cancer Research, Training and Community Service
癌症研究、培训和社区服务卓越中心
  • 批准号:
    9002855
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:
Center of Excellence for Cancer Research, Training and Community Service
癌症研究、培训和社区服务卓越中心
  • 批准号:
    8611733
  • 财政年份:
    2012
  • 资助金额:
    $ 234.09万
  • 项目类别:

相似国自然基金

基于卵巢癌细胞中心体蛋白调控网络的抗癌药物筛选研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
基于卵巢癌细胞中心体蛋白调控网络的抗癌药物筛选研究
  • 批准号:
    82272948
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
水环境中心血管药物辐照降解特性、机理与毒理效应研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
一氧化碳与水、氘水参与的不对称氢化反应研究
  • 批准号:
    21901096
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
中国医患治疗偏好研究:基于Best-worst标度法的探索
  • 批准号:
    71804122
  • 批准年份:
    2018
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 234.09万
  • 项目类别:
Randomized Control Trial of Nitazoxanide for the Treatment of Cryptosporidium Infection in Malnourished Children in Bangladesh
硝唑尼特治疗孟加拉国营养不良儿童隐孢子虫感染的随机对照试验
  • 批准号:
    10551559
  • 财政年份:
    2023
  • 资助金额:
    $ 234.09万
  • 项目类别:
Research Project 2
研究项目2
  • 批准号:
    10403256
  • 财政年份:
    2023
  • 资助金额:
    $ 234.09万
  • 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
  • 批准号:
    10367805
  • 财政年份:
    2023
  • 资助金额:
    $ 234.09万
  • 项目类别:
Bioinformatics Core
生物信息学核心
  • 批准号:
    10404414
  • 财政年份:
    2023
  • 资助金额:
    $ 234.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了